Cargando…

Employers Need to Have a Wider Horizon Than Drug Costs Alone When Considering the Implementation of Health Care Intervention Programs

The study of Mabasa and Ma in a previous issue of JMCP reports on the successful utilization and drug cost savings for proton pump inhibitors (PPIs) in a Canadian employer-sponsored drug plan that implemented a therapeutic maximum allowable cost (MAC) program.1 Any successful health care interventio...

Descripción completa

Detalles Bibliográficos
Autor principal: Wahlqvist, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438367/
https://www.ncbi.nlm.nih.gov/pubmed/16981804
http://dx.doi.org/10.18553/jmcp.2006.12.7.581

Ejemplares similares